Systemic therapy with single agents for advanced or recurrent endometrial carcinoma.
Thigpen
T
T
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D045167:Progesterone Congeners / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D045167:Progesterone Congeners; D013629:Tamoxifen